High Risk of Recurrence
3 clinical trials · Condition
◉ Watch High Risk of Recurrence
| Record | Firm | Date |
|---|---|---|
| Innovative Diagnosis and Therapy in LDLT Patients With High-risk Hepatocellular Carcinoma (NCT06327269) | Chang Gung Memorial Hospital | 2021-04-01 |
| Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (NCT02260505) | Centre Leon Berard | 2014-12-24 |
Track High Risk of Recurrence automatically
Every clearance here is in the API, with alerts when new ones post.